CRISPR Therapeutics (CRSP) stock Forecast for 2021 – 2025

CRISPR Therapeutics (CRSP) stock Forecast for 2022 – 2026

Last update: 05-21-2022, 7:46

Sector: Healthcare

The share price of CRISPR Therapeutics AG (CRSP) now

What analysts predict:: $121.86

52-week high/low: $169.76 / $42.51

50/200 Day Moving Average: $58.88 / $82.8

This figure corresponds to the average price over the previous 50/200 days. For CRISPR Therapeutics stocks, the 50-day moving average is the resistance level today.

For CRISPR Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in CRISPR Therapeutics AG stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the CRISPR Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one CRISPR Therapeutics share be worth in 2022 - 2026?

When should I take profit in CRISPR Therapeutics stock? When should I record a loss on CRISPR Therapeutics stock? What are analysts' forecasts for CRISPR Therapeutics stock? What is the future of CRISPR Therapeutics stock?

We forecast CRISPR Therapeutics stock performance using neural networks based on historical data on CRISPR Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

CRISPR Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for CRISPR Therapeutics shares. This happens once a day.




Historical and forecast chart of CRISPR Therapeutics stock

The chart below shows the historical price of CRISPR Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the CRISPR Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

CRISPR Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 23 57.83 56.98 59.37 4.21
May 24 57.64 56.08 59.09 5.36
May 25 56.17 54.61 57.77 5.78
May 26 56.06 54.55 57.41 5.25
May 27 56.35 55.00 57.65 4.81
May 28 57.00 55.44 58.39 5.33
May 29 56.05 54.74 57.44 4.92
May 30 56.32 55.59 57.49 3.41
May 31 58.05 56.93 59.25 4.07
Jun 01 56.55 55.23 57.53 4.17
Jun 02 56.90 55.45 58.27 5.09
Jun 03 57.60 56.43 58.85 4.31
Jun 04 59.32 58.64 60.60 3.33
Jun 05 60.57 59.19 61.02 3.11
Jun 06 61.07 59.60 62.67 5.16
Jun 07 62.11 60.43 63.65 5.32
Jun 08 63.72 62.30 65.60 5.30
Jun 09 65.65 64.58 67.13 3.95
Jun 10 65.67 64.94 67.08 3.29
Jun 11 66.79 66.05 68.10 3.11
Jun 12 67.83 65.85 68.38 3.85
Jun 13 68.16 67.35 69.06 2.55
Jun 14 68.08 66.39 69.97 5.39
Jun 15 70.17 69.31 72.14 4.08
Jun 16 69.91 68.90 71.75 4.13
Jun 17 70.61 69.85 72.31 3.52
Jun 18 71.45 70.04 72.11 2.94
Jun 19 68.88 67.30 70.05 4.09
Jun 20 70.10 68.83 71.97 4.56
Jun 21 70.75 69.31 72.32 4.34

CRISPR Therapeutics Daily Price Targets


CRISPR Therapeutics Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $57.83. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 4.036%.

Pessimistic target level: 56.98

Optimistic target level: 59.37


CRISPR Therapeutics Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $57.64. Negative dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 5.089%.

Pessimistic target level: 56.08

Optimistic target level: 59.09


CRISPR Therapeutics Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $56.17. Negative dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 5.468%.

Pessimistic target level: 54.61

Optimistic target level: 57.77


CRISPR Therapeutics Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $56.06. Negative dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 4.986%.

Pessimistic target level: 54.55

Optimistic target level: 57.41


CRISPR Therapeutics Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $56.35. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 4.594%.

Pessimistic target level: 55.00

Optimistic target level: 57.65


CRISPR Therapeutics Stock Forecast 05-28-2022.

Forecast target price for 05-28-2022: $57.00. Positive dynamics for CRISPR Therapeutics shares will prevail with possible volatility of 5.056%.

Pessimistic target level: 55.44

Optimistic target level: 58.39


CRSP (CRSP) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 54.10 47.60 59.20 19.59
Jul. 54.70 48.05 60.83 21.01
Aug. 57.77 50.65 61.83 18.09
Sep. 56.66 49.59 61.10 18.84
Oct. 58.20 54.19 60.25 10.05
Nov. 58.20 56.15 62.57 10.27
Dec. 66.48 60.95 74.89 18.61

CRISPR Therapeutics forecast for this year


CRISPR Therapeutics Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $54.0964. Pessimistic: $47.60. Optimistic: $59.20


CRISPR Therapeutics Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $54.7023. Pessimistic: $48.05. Optimistic: $60.83


CRISPR Therapeutics Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $57.7656. Pessimistic: $50.65. Optimistic: $61.83


CRISPR Therapeutics Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $56.6565. Pessimistic: $49.59. Optimistic: $61.10


CRISPR Therapeutics Stock Prediction for Oct 2022

An uptrend is forecast for this month with an optimal target price of $58.1975. Pessimistic: $54.19. Optimistic: $60.25


CRISPR Therapeutics Stock Prediction for Nov 2022

An downtrend is forecast for this month with an optimal target price of $58.1975. Pessimistic: $56.15. Optimistic: $62.57


CRISPR Therapeutics Stock Prediction for Dec 2022

An uptrend is forecast for this month with an optimal target price of $66.4849. Pessimistic: $60.95. Optimistic: $74.89




CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 61.59 54.69 64.94 15.78
Feb 65.43 57.27 72.55 21.07
Mar 61.25 59.09 67.03 11.84
Apr 59.68 53.00 64.74 18.14
May 56.91 54.09 60.73 10.94
Jun 65.29 58.92 68.00 13.36
Jul 67.59 60.02 73.75 18.62
Aug 74.61 69.60 77.12 9.75
Sep 81.54 76.71 89.89 14.66
Oct 82.71 78.08 89.86 13.11
Nov 81.26 75.67 90.23 16.14
Dec 94.13 88.86 102.11 12.98

CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 95.18 84.67 98.38 13.93
Feb 95.49 90.60 101.60 10.83
Mar 93.35 85.58 96.48 11.30
Apr 97.68 85.65 101.90 15.95
May 90.02 79.07 95.93 17.57
Jun 94.92 89.60 106.01 15.47
Jul 106.76 93.78 112.23 16.44
Aug 119.92 112.82 127.98 11.84
Sep 118.57 106.43 126.54 15.89
Oct 114.59 109.46 124.49 12.08
Nov 99.74 90.80 104.37 13.00
Dec 91.76 82.36 96.75 14.87



CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 98.51 88.74 106.40 16.59
Feb 91.11 87.02 101.16 13.98
Mar 87.75 84.10 94.21 10.73
Apr 99.27 95.45 102.44 6.82
May 107.21 102.06 114.93 11.19
Jun 111.67 102.02 115.24 11.47
Jul 105.06 98.16 115.65 15.12
Aug 107.41 96.24 112.05 14.11
Sep 115.66 111.40 126.39 11.86
Oct 109.00 104.99 118.59 11.47
Nov 109.17 103.06 113.01 8.81
Dec 112.67 104.19 122.22 14.75

CRISPR Therapeutics (CRSP) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 113.93 101.35 120.31 15.76
Feb 132.16 115.24 147.80 22.03
Mar 127.71 117.29 132.01 11.15
Apr 118.11 113.95 132.66 14.10
May 133.23 118.09 143.03 17.44
Jun 123.42 112.56 132.11 14.80
Jul 121.25 112.33 129.79 13.45
Aug 132.11 124.51 141.63 12.09
Sep 113.30 102.42 122.55 16.42
Oct 121.46 105.91 135.06 21.58
Nov 125.93 116.86 135.60 13.82
Dec 131.77 122.71 144.21 14.91

CRISPR Therapeutics information and performance

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan and Craig Mellow in 2014 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics Address

BAARERSTRASSE 14, ZUG, CH

Market Capitalization: 4 026 608 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: 391 481 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: 11.06

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 4.7

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: 33.86

Trailing PE: 11.06

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 23.36

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 1.773

Enterprise Value (EV) /Revenue

EV To EBITDA: 4.867

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 77457000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.